<DOC>
	<DOCNO>NCT00104689</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , capecitabine oxaliplatin , work different way stop growth tumor cell , either kill cell stop dividing . PURPOSE : This phase II trial study well give capecitabine together oxaliplatin work treat old patient metastatic colorectal cancer .</brief_summary>
	<brief_title>Capecitabine Oxaliplatin Treating Older Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine efficacy capecitabine oxaliplatin first-line treatment , define stabilization improvement 1 point Katz 's Activities Daily Living scale , old patient metastatic colorectal adenocarcinoma . Secondary - Determine toxicity regimen patient . - Determine percentage patient receive first 3 course regimen ( low dos ) percentage patient receive 6 course regimen ( low high dos ) . - Determine efficacy regimen , define RECIST criterion , patient . - Determine pharmacokinetics regimen patient . OUTLINE : This multicenter , open-label , nonrandomized study . Patients receive oral capecitabine* daily day 1-14 oxaliplatin* IV day 1 . Treatment repeat every 21 day 6 course absence disease progression unacceptable toxicity . NOTE : *The dos capecitabine oxaliplatin increased course 4-6 absence unacceptable toxicity PROJECTED ACCRUAL : A total 60 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis colorectal adenocarcinoma Metastatic disease Requires firstline therapy metastatic disease PATIENT CHARACTERISTICS : Age Over 70 Performance status Katz 's Activities Daily Living scale &lt; 6 ( ≤ 6 patient ≥ 80 year age ) Life expectancy More 3 month Hematopoietic Absolute neutrophil count &gt; 1,500/mm^3 Platelet count &gt; 100,000/mm^3 Hepatic AST ALT &lt; 2 time normal ( 5 time normal due hepatic metastasis ) Bilirubin &lt; 2 time normal ( 5 time normal due hepatic metastasis ) Renal Creatinine clearance &gt; 30 mL/min Other No clinical neuropathy PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy More 6 month since prior adjuvant chemotherapy No prior chemotherapy metastatic disease Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>